Key result
Nicardipine therapy linked to reduced systemic vascular resistance and increased cardiac index at rest and exercise.
Why the study?
Does oral nicardipine improve rest and exercise hemodynamics in patients with severe, chronic congestive heart failure?
Does oral nicardipine improve rest and exercise hemodynamics in patients with severe, chronic congestive heart failure?
Nicardipine-mediated vasodilation significantly improves both rest and exercise cardiac performance in patients with severe chronic congestive heart failure without causing negative inotropic effects or reflex sympathetic activation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for nicardipine in severe HF; larger randomized trials needed before any practice consideration.
The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure. Rest and exercise hemodynamics were evaluated in the baseline state and after 1 week of oral nicardipine therapy (30 mg 3 times daily). In addition, respiratory gas exchange and arteriovenous oxygen difference were measured to assess changes in oxygen utilization. The responses of the sympathetic nervous system were evaluated by measuring plasma norepinephrine concentrations at rest and during maximal exercise. At rest, nicardipine administration was associated with significant reductions in mean systemic arterial pressure, systemic vascular resistance, pulmonary artery wedge pressure and pulmonary arterial pressure, and significant increases in cardiac index and stroke volume index. These effects were maintained during exercise. In contrast to findings with other calcium channel antagonists, no negative inotropic effect of nicardipine was identified. Nicardipine administration was associated with reduction of arteriovenous oxygen difference. Nicardipine had no effect on plasma norepinephrine concentrations, suggesting absence of reflex sympathetic nervous activation. Thus, nicardipine-mediated vasodilation leads to significant improvements in both rest and exercise cardiac performance.
No takes yet. Share an insight, caveat, or question.
Ryman et al. (1986) studied severe, chronic congestive heart failure (n=10). nicardipine vs. baseline was evaluated on Rest and exercise hemodynamics. Nicardipine therapy significantly reduced systemic arterial pressure and vascular resistance, and increased cardiac index and stroke volume index at rest and during exercise.
Synapse has enriched 10 related papers. Consider them for comparative context: